1-8 of 8
Lily LL Wong
Close
Sort by
Journal Articles

Dose-Exposure-Response Relationships of Biomarkers and Efficacy Measures with Iptacopan, a Complement Factor B Inhibitor, in Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) with or without Concomitant Anti-C5 Therapy

Antonio Risitano, Régis Peffault de Latour, Eng Soo Yap, Lily LL Wong, Bor-Sheng Ko, Sung-Soo Yoon, Alexander Roeth, Irina Baltcheva, Julie Milojevic, Niamh Fagan, Kenneth Kulmatycki, Prasanna K Nidamarthy, Guido Junge, Jun Ho Jang
Journal: Blood
Blood (2022) 140 (Supplement 1): 5803–5804.
https://doi.org/10.1182/blood-2022-160114
Published: 2022
Journal Articles

Risk Factors and Outcome of COVID-19 Infection in Haematological Patients : A Multicenter Retrospective Analysis in Malaysia

Sui Keat, Ai Sim Goh, Carol Chew Yuen Goh, Hong Siew Tan, Tee Chuan Ong, Sen Mui Tan, Pei Ling Low, Kuldeep Kaur, Ee Leng Gan, See Guan Toh, Tze Shin Leong, Lee Ping Chew, Hock Hin Chua, Lily LL Wong, Gilbert Wilfred, Shan Shan Tan, Christopher Liam, Yang Liang Boo
Journal: Blood
Blood (2022) 140 (Supplement 1): 13232–13233.
https://doi.org/10.1182/blood-2022-165307
Published: 2022
Journal Articles

Sensitivity Analysis on the Primary Efficacy Results of SB12 (Eculizumab Biosimilar) Phase III Study in Paroxysmal Nocturnal Hemoglobinuria Patients

Jun Ho Jang, Roberta Demichelis, Larysa Nogaieva, Lily LL Wong, Soo Min Lim, Younsoo Kim, Jihye Park
Journal: Blood
Blood (2022) 140 (Supplement 1): 8658–8659.
https://doi.org/10.1182/blood-2022-158387
Published: 2022
Journal Articles

Gilteritinib Versus Salvage Chemotherapy for Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Phase 3, Randomized, Multicenter, Open-Label Trial in Asia

Jianxiang Wang, Bin Jiang, Jian Li, Ligen Liu, Xin Du, Hao Jiang, Jianda Hu, Menghe Yuan, Taishi Sakatani, Takeshi Kadokura, Masato Takeuchi, Shunsuke Izuka, Larisa Girshova, Jerome Tan, Sergey N. Bondarenko, Lily LL Wong, Archrob Khuhapinant, Elena Martynova, Nahla Hasabou, Ramon V. Tiu
Journal: Blood
Blood (2021) 138 (Supplement 1): 695.
https://doi.org/10.1182/blood-2021-145436
Published: 2021
Journal Articles

12-Month Analysis of a Phase 2 Study of Iptacopan (LNP023) Monotherapy for Paroxysmal Nocturnal Hemoglobinuria

Jun-Ho Jang, Lily LL Wong, Bor-Sheng Ko, Sung-Soo Yoon, Katie Li, Izabela Rozenberg, Prasanna K Nidamarthy, Raghav Chawla, Guido Junge, Eng Soo Yap
Journal: Blood
Blood (2021) 138 (Supplement 1): 2173.
https://doi.org/10.1182/blood-2021-152518
Published: 2021
Journal Articles

Surgeries and Diagnostic Procedures in Hemophilia Patients on Concizumab Prophylaxis: Results from the Phase 2 Explorer4 and Explorer5 Trials

Allison P. Wheeler, Gary Benson, Hermann Eichler, Sidsel Marie Tønder, Katarina Cepo, Victor Jimenez Yuste, Kaan Kavakli, Lily LL Wong, Tadashi Matsushita
Journal: Blood
Blood (2021) 138 (Supplement 1): 345.
https://doi.org/10.1182/blood-2021-148571
Published: 2021
Journal Articles

Efficacy and Safety of Concomitant Use of Ravulizumab and IST in Patients with Paroxysmal Nocturnal Hemoglobinuria up to 52 Weeks

Hubert Schrezenmeier, Jong Wook Lee, MD, PhD, Anita Hill, Vadim V Ptushkin, Viviani Pessoa, Rosario Notaro, Jimmy Wang, Masayo Ogawa, MD FAAP, Shinichiro Okamoto, MD PhD, Lily LL Wong, MD FRCPath, Regis Peffault De Latour, MD PhD, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-142453
Published: 2020
Journal Articles

Breakthrough Hemolysis in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: Results of a 52-Week Extension from Two Phase 3 Studies

Anita Hill, MD PhD, Caroline I. Piatek, Régis Peffault de Latour, MD PhD, Lily LL Wong, MD FRCPath, Richard A. Wells, MD DPhil, Robert A. Brodsky, MD, Jin Seok Kim, MD PhD, Junichi Nishimura, MD PhD, Philip Kuriakose, MD, Rodrigo Pavani, Peng Liu, Stephan Ortiz, RPh, PhD, Hubert Schrezenmeier, MD, Jong-Wook Lee, MD PhD, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath
Journal: Blood
Blood (2019) 134 (Supplement_1): 952.
https://doi.org/10.1182/blood-2019-128929
Published: 2019